These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35874751)

  • 41. Booster BNT162b2 COVID-19 Vaccination Increases Neutralizing Antibody Titers Against the SARS-CoV-2 Omicron Variant in Both Young and Elderly Adults.
    Um J; Choi YY; Kim G; Kim MK; Lee KS; Sung HK; Kim BC; Lee YK; Jang HC; Bang JH; Chung KH; Oh MD; Park JS; Jeon J
    J Korean Med Sci; 2022 Mar; 37(9):e70. PubMed ID: 35257525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.
    Wu D; Ye Y; Tang L; Wang AB; Zhang R; Qian ZH; Wang FZ; Zheng H; Huang C; Lv XY; Wang HF; Zhang YY; Pan JJ; Li YF; Lu MX; Wang CS; Ma YT; An ZJ; Rodewald LE; Yin ZD; Wang XY; Wu ZY; Shao YM
    Emerg Microbes Infect; 2022 Dec; 11(1):1950-1958. PubMed ID: 35850623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant.
    Zuo F; Abolhassani H; Du L; Piralla A; Bertoglio F; de Campos-Mata L; Wan H; Schubert M; Cassaniti I; Wang Y; Sammartino JC; Sun R; Vlachiotis S; Bergami F; Kumagai-Braesch M; Andréll J; Zhang Z; Xue Y; Wenzel EV; Calzolai L; Varani L; Rezaei N; Chavoshzadeh Z; Baldanti F; Hust M; Hammarström L; Marcotte H; Pan-Hammarström Q
    Nat Commun; 2022 May; 13(1):2670. PubMed ID: 35562366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques.
    Deng W; Lv Q; Li F; Liu J; Song Z; Qi F; Wei Q; Yu P; Liu M; Zhou S; Zhang Y; Gao H; Wang N; Jia Z; Gao K; Liu J; Xiao C; Shang H; Wang X; Bao L; Qin C
    Signal Transduct Target Ther; 2022 Apr; 7(1):124. PubMed ID: 35436986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years.
    Alidjinou EK; Demaret J; Corroyer-Simovic B; Labreuche J; Goffard A; Trauet J; Lupau D; Miczek S; Vuotto F; Dendooven A; Huvent-Grelle D; Podvin J; Dreuil D; Faure K; Deplanque D; Bocket L; Duhamel A; Sobaszek A; Hober D; Hisbergues M; Puisieux F; Autran B; Yazdanpanah Y; Labalette M; Lefèvre G
    Lancet Reg Health Eur; 2022 Jun; 17():100385. PubMed ID: 35469147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination.
    Takheaw N; Liwsrisakun C; Chaiwong W; Laopajon W; Pata S; Inchai J; Duangjit P; Pothirat C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A; Tajarernmuang P; Niyatiwatchanchai N; Trongtrakul K; Kasinrerk W
    Diagnostics (Basel); 2022 May; 12(6):. PubMed ID: 35741126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice.
    Hu L; Xu Y; Wu L; Feng J; Zhang L; Tang Y; Zhao X; Mai R; Chen L; Mei L; Tan Y; Du Y; Zhen Y; Su W; Peng T
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants.
    Muñoz-Alía MÁ; Nace RA; Balakrishnan B; Zhang L; Packiriswamy N; Singh G; Warang P; Mena I; Narjari R; Vandergaast R; García-Sastre A; Schotsaert M; Russell SJ
    bioRxiv; 2022 Dec; ():. PubMed ID: 36561187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates.
    Walters JN; Schouest B; Patel A; Reuschel EL; Schultheis K; Parzych E; Maricic I; Gary EN; Purwar M; Andrade VM; Doan A; Elwood D; Eblimit Z; Nguyen B; Frase D; Zaidi FI; Kulkarni A; Generotti A; Joseph Kim J; Humeau LM; Ramos SJ; Smith TRF; Weiner DB; Broderick KE
    Vaccine; 2022 May; 40(21):2960-2969. PubMed ID: 35428500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine.
    Chen Q; Du P; Han Y; Ma X; Zhang R; Rong X; Zhao X; Ma R; Yang H; Zheng A; Huang Q; Yan J; Wang H; Zhao X; Dai L; Gao GF; Wang Q
    Biosaf Health; 2023 Apr; 5(2):89-100. PubMed ID: 37123450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8
    Parham KA; Kim GN; Richer CG; Ninkov M; Wu K; Saeedian N; Li Y; Rashu R; Barr SD; Arts EJ; Haeryfar SMM; Kang CY; Troyer RM
    iScience; 2023 Apr; 26(4):106292. PubMed ID: 36915805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review.
    K A; Sharma A; Kumar D; Singh SK; Gupta G; Chellappan DK; Dua K; Nagraik R
    J Med Virol; 2022 Oct; 94(10):4628-4643. PubMed ID: 35705439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster model.
    van Doremalen N; Schulz JE; Adney DR; Saturday TA; Fischer RJ; Yinda CK; Thakur N; Newman J; Ulaszewska M; Belij-Rammerstorfer S; Saturday G; Spencer AJ; Bailey D; Gilbert SC; Lambe T; Munster VJ
    Res Sq; 2022 Feb; ():. PubMed ID: 35194602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy.
    Azar JH; Evans JP; Sikorski MH; Chakravarthy KB; McKenney S; Carmody I; Zeng C; Teodorescu R; Song NJ; Hamon JL; Bucci D; Velegraki M; Bolyard C; Weller KP; Reisinger SA; Bhat SA; Maddocks KJ; Denlinger N; Epperla N; Gumina RJ; Vlasova AN; Oltz EM; Saif LJ; Chung D; Woyach JA; Shields PG; Liu SL; Li Z; Rubinstein MP
    JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36749632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals.
    Naranbhai V; Nathan A; Kaseke C; Berrios C; Khatri A; Choi S; Getz MA; Tano-Menka R; Ofoman O; Gayton A; Senjobe F; Denis KJS; Lam EC; Garcia-Beltran WF; Balazs AB; Walker BD; Iafrate AJ; Gaiha GD
    medRxiv; 2022 Jan; ():. PubMed ID: 35018386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
    Naranbhai V; Nathan A; Kaseke C; Berrios C; Khatri A; Choi S; Getz MA; Tano-Menka R; Ofoman O; Gayton A; Senjobe F; Zhao Z; St Denis KJ; Lam EC; Carrington M; Garcia-Beltran WF; Balazs AB; Walker BD; Iafrate AJ; Gaiha GD
    Cell; 2022 Mar; 185(6):1041-1051.e6. PubMed ID: 35202566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2-Spike Antibody and T-Cell Responses Elicited by a Homologous Third mRNA COVID-19 Dose in Hemodialysis and Kidney Transplant Recipients.
    Panizo N; Giménez E; Albert E; Zulaica J; Rodríguez-Moreno A; Rusu L; Giménez-Civera E; Puchades MJ; D'Marco L; Gandía-Salmerón L; Torres I; Sancho A; Gavela E; Gonzalez-Rico M; Montomoli M; Perez-Baylach CM; Bonilla B; Solano C; Alvarado MF; Torregrosa I; Gonzales-Candia B; Alcaraz MJ; Geller R; Górriz JL; Navarro D
    Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36422345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice.
    Ying B; Scheaffer SM; Whitener B; Liang CY; Dmytrenko O; Mackin S; Wu K; Lee D; Avena LE; Chong Z; Case JB; Ma L; Kim T; Sein C; Woods A; Berrueta DM; Carfi A; Elbashir SM; Edwards DK; Thackray LB; Diamond MS
    bioRxiv; 2022 Feb; ():. PubMed ID: 35169795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice.
    Cotter CA; Americo JL; Earl PL; Moss B
    NPJ Vaccines; 2023 Mar; 8(1):47. PubMed ID: 36973267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.